EUVIMEDEUVIMED entdecken
Open Access

Genetic Information Enhances a Novel Non‐Invasive Steatosis Index and Outperforms Existing Steatosis Indices

Yousif Alyousifi iD, Chinmay Raut iD, Vincent L Chen iD, Antonino Oliveri iD, Yanhua Chen, Elizabeth K Speliotes

Liver International · 2026

DOI: 10.1111/liv.70410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Yousif Alyousifi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Early detection of individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) is important as interventions to reduce steatosis can prevent progression to advanced liver disease. Identification of individuals with hepatic steatosis relies on imaging techniques, which are costly and often unavailable in large populations. Identifying hepatic steatosis through blood tests and demographics may serve as a cost‐effective alternative to identifying hepatic steatosis. Here, we aim to identify demographic, serum and genetic variables that can help predict hepatic steatosis in two large population‐based cohorts.

Methods

We analysed data from 32 008 participants in the UK Biobank (UKBB) with liver fat quantified using magnetic resonance proton density fat fraction (MRI‐PDFF). We created non‐invasive models to predict steatosis, the Enhanced Steatosis Indexes (ESIs), using logistic regression. Candidate predictors included variables from the literature and genetic markers. ESI‐1 variables included demographic and serum values. ESI‐2 included the ESI‐1 variables plus the genetic markers. We trained and tested these models in UKBB and validated them in the Framingham Heart Study (FHS).

Results

In UKBB, ESI‐1 and ESI‐2 predicted ≥ 5% PDFF with AUC 0.844 and 0.858, respectively, outperforming DSI, HSI, FSI and FLI (AUC 0.818–0.834 vs. ESI‐1 and AUC 0.830–0.844 vs. ESI‐2). In FHS, ESI‐1 and ESI‐2 predicted CT‐measured liver steatosis with AUC 0.803 and 0.808, respectively.

Conclusions

We developed a non‐invasive model to diagnose steatosis that outperforms existing steatosis models. Including genetic information improved the performance of ESI‐2. Deployment of our models can facilitate non‐invasive screening of steatosis so that, with early intervention, disease progression can be prevented. Impact and Implications We developed a non‐invasive model based on demographic, serum laboratory and genetic predictors that outperforms existing steatosis indices in identifying individuals with hepatic steatosis. This Enhanced Steatosis Index (ESI) enables more accurate and personalised early detection of hepatic steatosis, a highly prevalent yet underdiagnosed condition. By leveraging readily available clinical measures and genetic data, both ESI‐1 and ESI‐2 improve risk stratification and support large‐scale screening and early intervention efforts. These advances have the potential to provide more affordable, accurate and targeted screening, facilitating earlier treatment, reducing the burden of metabolic liver disease and helping to address disparities in the diagnosis and management of hepatic steatosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverNon-alcoholic Fatty Liver DiseaseHumansFemaleMagnetic Resonance ImagingMaleMiddle AgedUnited KingdomLogistic ModelsGenetic MarkersAgedLiverBiomarkersUK BiobankEarly Diagnosis

Stichwörter der Autor:innen

blood testhepatic steatosisliver steatosismachine learningnon‐invasive scorepolygenic risk score

Substanzen

Genetic MarkersBiomarkers

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Yousif Alyousifi, Chinmay Raut, Vincent L Chen, Antonino Oliveri

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Alyousifi, Y., Raut, C., Chen, V. L., Oliveri, A., Chen, Y., & Speliotes, E. K. (2026). Genetic Information Enhances a Novel Non‐Invasive Steatosis Index and Outperforms Existing Steatosis Indices. Liver International. https://doi.org/10.1111/liv.70410

Vancouver

Alyousifi Y, Raut C, Chen VL, Oliveri A, Chen Y, Speliotes EK. Genetic Information Enhances a Novel Non‐Invasive Steatosis Index and Outperforms Existing Steatosis Indices. Liver International. 2026. doi:10.1111/liv.70410

BibTeX
@article{Alyousifi2026,
  author = {Alyousifi, Yousif and Raut, Chinmay and Chen, Vincent L and Oliveri, Antonino and Chen, Yanhua and Speliotes, Elizabeth K},
  title = {Genetic Information Enhances a Novel Non‐Invasive Steatosis Index and Outperforms Existing Steatosis Indices},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70410}
}
Kostenlos starten →